Cartesian Therapeutics Inc. followed up December’s phase IIb data with more good news regarding Descartes-08, offering 12-month efficacy and safety results that whetted Wall Street’s appetite for the ...

A natural antioxidant found in foods like kale and berries, kaempferol, may help protect nerve cells and shows promise as a ...

Explore Solid Biosciences’ potential with promising SGT-003 trial results for DMD, strong financials, and market recovery ...

A team at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) has developed an innovative gene-therapy strategy ...

Array Bridge is testing promising drug candidates that can effectively bind and even degrade target proteins, but not via their active sites.

Epigenetic changes in the placenta may shape how the fetal brain develops and thus influence the risk of psychiatric ...

A new article argues dystrophin immunogenicity is an under-examined issue in the treatment of Duchenne muscular dystrophy.

A key protein network that keeps cells safe from the dangerous effects of transposable elements has been uncovered.

Nanotechnology offers a next-gen solution to plant genome editing challenges by enabling precise, efficient delivery of CRISPR, RNA, and DNA tools using nanoparticles like AuNPs, CNTs, and lipid ...

Research analysts at StockNews.com initiated coverage on shares of Enzo Biochem (NYSE:ENZ – Get Free Report) in a research report issued on Tuesday. The brokerage set a “hold” rating on the medical ...

A study from Stanford researchers identifies the CXCL12 gene as a crucial regulator of the posterior descending artery’s ...